Dr. Ana Oaknin is the Head of the Gynaecological Cancer Programme at the Hospital Puerta de Hierro, Majadahonda, in Madrid, Spain and a prominent figure in the field of Gynaecological Oncology, internationally. Dr. Oaknin is an active faculty member of the European Society of Medical Oncology (ESMO) Gynaecologic Track. She has served as Scientific Commit Member for ESMO Meeting in the last few years, as Subject Editor for Gynaecologic Malignancies Guidelines (2022-2024) and she is chair of the ESMO gynaecological cancer congress (2024-2026). Dr. Oaknin has been the Gynaecologic Cancer Intergroup (GCIG) Cervical Cancer Committee Chair from 2022-2224 and is an active member of American Society of Clinical Oncology (ASCO), Society of Gynaecologic Oncology (SGO) where she serves as International Member on the Board Committee. Dr. Oaknin obtained her degree in Medicine and Surgery from the Complutense University of Madrid in 1994 and specialized in Medical Oncology at the Hospital Universitario de la Princesa, Universidad Complutense de Madrid, becoming board certified in 2000. She earned her PhD Cum Laude from the Universidad Autónoma de Barcelona in 2016. Throughout her career, Dr Oaknin has been primarily focused on clinical research, serving as the principal investigator for numerous Phase I, II, and III studies, both nationally and internationally. She is the author of many outstanding articles in high impact journals.